SCHEMBL14174341

SCHEMBL14174341

CC1CCC(N(C(=O)OCc2ccccc2)c2ccccc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.59
CHRM3 P20309 11/20 0.56
CHRM1 P11229 9/20 0.56
CHRM5 P08912 8/20 0.56
CHRM2 P08172 6/20 0.56
CCNK O75909 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
CDK12 Q9NYV4 1/20 0.45
SIGMAR1 Q99720 3/20 0.44
OPRM1 P35372 3/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44
ALDH1A1 P00352 1/20 0.44
SLC22A1 O15245 1/20 0.43
NR1I2 O75469 1/20 0.43
ABCB1 P08183 1/20 0.43
DRD2 P14416 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
MAOA P21397 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13503640 0.86 ENPP2 (0.56) ENPP2CHRM3CHRM1CHRM5CHRM2
SCHEMBL13681468 0.79 CHRM3 (0.65) CHRM3CHRM1CHRM2SIGMAR1OPRM1
SCHEMBL7110222 0.77 ENPP2 (0.64) ENPP2CHRM3CHRM1CHRM5CHRM2
SCHEMBL1058888 0.77 SIGMAR1 (0.60) ENPP2CHRM3CHRM1CHRM5CHRM2
SCHEMBL13681469 0.76 OPRD1 (0.49) CHRM3CHRM1CHRM2SIGMAR1OPRM1
SCHEMBL7110221 0.76 ENPP2 (0.62) ENPP2CHRM3CHRM1CHRM5CHRM2
SCHEMBL14409748 0.76 CCNK (0.56) CCNKCCNA2CDK2CDK12SIGMAR1
SCHEMBL4805754 0.75 SIGMAR1 (0.55) ENPP2CHRM3CHRM1CHRM5CHRM2
SCHEMBL4803972 0.75 SIGMAR1 (0.55) ENPP2CHRM3CHRM1CHRM5CHRM2
SCHEMBL4803965 0.75 SIGMAR1 (0.55) ENPP2CHRM3CHRM1CHRM5CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-06-19 US disclosed
US-7358251-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES (US) 2008-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS BAX, BCL2, BAD ENPP2 2114/4885CHRM3 4504/4885CHRM1 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.